Alnylam Pharmaceuticals Inc (ALNY)
Market Closed
17 Jul, 20:00
$
267. 47
-15.68
-5.5377%
$
37.27B Market Cap
- P/E Ratio
- Div Yield
1.38M Volume
-3.56 Eps
$ 283.15
Previous Close 
Want to track ALNY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alnylam Pharmaceuticals Inc (ALNY) Statistics
Valuation metrics
Market Cap 37.27B
Enterprise value 35.27B
Trailing P/E (ttm) 61.35
Forward P/E 21.35
PEG ratio 0.03
Price/Sales (ttm) 8.33
Price/Book (mrq) 33.05
Enterprise Value/Revenue 8.23
Enterprise Value/EBITDA 38.15
Overview
Shares outstanding 133.44M
Float 132.96M
Shares short 5.03M
% Held by insiders 0%
% Held by institutions 1.01%
Average volume (10 days) 1.61M
Average volume (90 days) 1.18M
Price summary
52-Week low 266.43
52-Week high 495.55
Beta 0.3
50-Day moving average 291.39
200-Day moving average 323.12
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.13%
Operating margin 0.18%
Operational effectiveness
Return on assets 0.11%
Return on equity 0.98%
Income Statement
Revenue (ttm) 4.29B
Revenue per share (ttm) 32.26
Quarterly revenue growth (yoy) 0.96%
Gross profit (ttm) 3.46B
EBITDA 909.4M
Net income to common (ttm) 537.99M
Diluted EPS (ttm) 4.34
Quarterly earnings growth (yoy) 0.96%
Balance Sheet
Total cash (mrq) 3.01B
Total cash per share (mrq) 22.64
Total debt (mrq) 2.97B
Total Debt/Equity (mrq) 1.18
Current ratio (mrq) 3.13%
Book value per share (mrq) 8.09
Cash Flow
Cash flow statement 714.9M
Levered free cash flow (LFCF) 204.71M
